The EGFR Resisters has a new multi-year research partnership with the Lung Cancer Research Foundation (LCRF). LCRF is a large non-profit lung cancer advocacy organization based in New York whose mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment, and cure of lung cancer.
For 2021, we have the opportunity to partner with LCRF to fund a new two-year $150,000 research project related to EGFR positive lung cancer. LCRF matched the money the EGFR Resisters raised dollar for dollar, so we only needed to raise $75,000 to make a difference. However, because of the enthusiastic fundraising of our members, we exceeded our goal and now have boosted our goal to $225,000. This additional amount will finance two additional research projects that we will fund through our collaboration with LCRF in 2022.